Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge

Burns

Volumn 31, Issue 2, 2005, Pages 153-158

  Neely, Alice N ^a,b   Holder, Ian A ^b   Wiener Kronish, Jeanine P ^c   Sawa, Teiji ^c  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Immunotherapy; PcrV; Pseudomonas aeruginosa; Type III secretion phenotype

Indexed keywords

ANTIBODY; ANTISERUM; IMMUNOGLOBULIN; PCRV ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CONTROLLED STUDY; FEMALE; GENOTYPE; GRAM NEGATIVE INFECTION; IMMUNOBLOTTING; LETHAL DOSE; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; RABBIT; SURVIVAL;

EID: 15944399760     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2004.09.002     Document Type: Article

References (22)

1. C.G. Mayhall The epidemiology of burn wound infections: then and now Clin Infect Dis 37 2003 543 550
2. E.E. Tredget, H.A. Shankowsky, R. Rennie, R.E. Burrell, and S. Logsetty Pseudomonas infection in the thermally injured patient Burns 30 2004 3 26
3. I.A. Holder Pseudomonas vaccination and immunotherapy J Burn Care Rehabil 22 2001 311 320
4. J.E. Galan, and A. Collmer Type III secretion machines: bacterial devices for protein delivery into host cells Science 284 1999 1322 1328
5. A. Gauthier, and B.B. Finlay Type III secretion system inhibitors are potential antimicrobials ASM News 68 2002 383 387
6. I.A. Holder, A.N. Neely, and D.W. Frank Type III secretion/intoxication system important in virulence of Pseudomonas aeruginosa infections in burns Burns 27 2001 129 130
7. I.A. Holder, A.N. Neely, and D.W. Frank PcrV immunization enhances survival in burned Pseudomonas aeruginosa-infected mice Infect Immun 69 2001 5908 5910
8. S. Kulich, T.L. Yahr, L. Mende-Mueller, J.T. Barbieri, and D.W. Frank Cloning the structural gene for the 49-kDa form of exoenzyme S (exoS) from Pseudomonas aeruginosa strain 388 J Biol Chem 269 1994 10431 10437
9. T.L. Yahr, J.T. Barbieri, and D.W. Frank Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa J Bacteriol 178 1996 1412 1419
10. V. Finck-Barbancon, J. Goranson, and L. Zhu ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury Mol Microbiol 25 1997 547 557
11. T.L. Yahr, A.J. Vallis, M.K. Hancock, J.T. Barbiere, and D.W. Frank ExoY, a novel adenylate cyclase secreted by the Pseudomonas aeruginosa type III system Proc Natl Acad Sci USA 95 1998 13899 13904
12. S.M.J. Fleiszig, J.P. Wiener-Kronish, and H. Miyazaki Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S Infect Immun 65 1997 579 586
13. P. Berthelot, I. Attree, and P. Plesiat Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes J Infect Dis 188 2003 512 518
14. T. Sawa, T.L. Yahr, and M. Ohara Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury Nat. Med 5 1999 392 399
15. D.W. Frank, A. Vallis, and J.R. Wiener-Kronish Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV J Infect Dis 186 2002 64 73
16. A.N. Neely, I.A. Holder, and G.D. Warden Then and now: studies using a burned mouse model reflect trends in burn research over the past 25 years Burns 25 1999 603 609
17. A.N. Neely, and I.A. Holder A murine model with aspects of clinical relevance for the study of antibiotic-induced endotoxin release in septic hosts J Endotox Res 3 1996 229 235
18. I.A. Holder, and A.N. Neely Combined host specific and anti-Pseudomonas directed therapy for Pseudomonas aeruginosa infections in burned mice: experimental results and theoretical conditions J Burn Care Rehabil 10 1989 131 137
19. 2 in sepsis associated with Pseudomonas aeruginosa J Immunol 167 2001 5880 5886
20. T. Ajayi, L.R. Allmond, T. Sawa, and P. Wiener-Kronish Single-nucleotide-polymorphism mapping of the Pseudomonas aeruginosa type III secretion toxins for development of a diagnostic multiplex PCR system J Clin Microbiol 41 2003 3526 3531
21. A.N. Neely, and I.A. Holder The use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns G. Doring I.A. Holder K. Bozenhart Basic research and clinical aspects of Pseudomonas aeruginosa 1987 Karger Medical and Scientific Publishers Basel 26 40
22. K. Faure, D. Shimabukuro, T. Ajayi, L.R. Allmond, T. Sawa, and J.P. Wiener-Kronish O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa J Clin Microbiol 41 2003 2158 2160